(MedPage Today) -- Among young hospital patients, factors like older age and the presence of multiple medical conditions were associated with higher rates of hospital-associated venous thromboembolism (VTE), a retrospective study showed.
NEW ORLEANS (MedPage Today) -- Two research groups have filled in another piece of the pathogenetic puzzle of myeloproliferative neoplasms.
(MedPage Today) -- The risk of bleeding, stroke, and pump thrombosis after receipt of a continuous flow left ventricular assist device (CF-LVAD) differed by demographic group and was most common in women, a retrospective analysis reported.
SAN ANTONIO (MedPage Today) -- Anastrozole (Arimidex) reduced the risk of breast cancer by 53% in high-risk postmenopausal women, a primary prevention trial showed.
NEW ORLEANS (MedPage Today) -- For older patients newly diagnosed with multiple myeloma, treatment efficacy was similar with any of three investigational drug regimens, a researcher said here. One regimen, however, produced significantly greater hematological toxicity.
(MedPage Today) -- GAITHERSBURG, Md. -- A panel of FDA advisers gave strong backing to an implantable device that's an alternative to blood-thinners for stroke prevention in patients with atrial fibrillation.
NEW ORLEANS (MedPage Today) -- An all-oral combination regimen for multiple myeloma produced a 94% response rate in a phase I-II clinical trial.
SAN ANTONIO (MedPage Today) -- The addition of bevacizumab (Avastin) to standard adjuvant therapy for HER2-positive breast cancer failed to improve invasive disease-free survival in a randomized clinical trial.
(MedPage Today) -- An FDA advisory committee has backed a leptin analog for treating generalized lipodystrophy, but wants more evidence for a broader indication in partial lipodystrophy with other metabolic complications.
SAN ANTONIO (MedPage Today) -- Complete pathologic responses seen with neoadjuvant trastuzumab (Herceptin) and lapatinib (Tykerb) among breast cancer patients correlated with better survival, according to a clinical trial subanalysis.